Induction of autocytotoxic T cells with cyclosporine and Interferon-γ for patients with non-Hodgkin's lymphoma after transplantation of peripheral blood stem cells

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 SUPPL., 1997, Pages

  Nakao, Shinji ^a   Miura, Yuji ^a   Zeng, Weihua ^a   Takami, Akiyoshi ^a   Sugimori, Naomi ^a   Yamazaki, Hirohito ^a   Yachie, Akihiro ^a   Shiobara, Shintaro ^a   Matsuda, Tamotsu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Autologous graft versus host disease; Cyclosporine; Interferon ; Non hodgkin's lymphoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PHYTOHEMAGGLUTININ; PREDNISOLONE; RANIMUSTINE; RECOMBINANT GAMMA INTERFERON; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; CELL SELECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AUTOIMMUNITY; CYCLOSPORINE; CYTOTOXICITY, IMMUNOLOGIC; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA, RECOMBINANT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031398703     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70007-1     Document Type: Article

References (20)

1. Armitage JO, Antmen KH. High-dose cancer therapy, pharmacology, hematopoiesis, stem cells. 2nd ed. Baltimore: Williams & Willkins, 1995:757.
2. Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995;333:1540-5.
3. Vose JM, Anderson JR, Kessinger A, et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1993;11:1846-51.
4. Schmitz N, Linch DC, Dreger P, et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996;347:353-7.
5. Mills W, Chopra R, McMillan A, et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 1995;13:588-95.
6. Nademanee A, Schmidt GM, O'Donnell MR, et al. High-dose chemoradiotherapy followed by autologous bone marrow transplan-tation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood 1992;80:1130-4.
7. Sharp JG, Kessinger A, Mann S, et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J Clin Oncol 1996;14:214-9.
8. Haioun C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. J Clin Oncol 1994;12:2543-51.
9. Verdonck LF, van PW, Hagenbeek A, et al. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 1995;332:1045-51.
10. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994;64:2061-7.
11. Talbot DC, Powles RL, Sloan JP, et al. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukemia. Bone Marrow Transplant 1990;6:17-20.
12. Jones RJ, Vogelsang GB, Ambinger RF, et al. Autologous marrow transplant with cyclosporine induced autologous graft-versus-host disease for relapsed aggressive non-Hodgkin's lymphoma. Blood 1991;78 (Suppl):287a.
13. Hess AD, Horwitz L, Beschorner WE, et al. Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation, I: development of cytotoxic T lymphocytes with apparent polydonal anti-Ia specificity, including autoreactivity. J Exp Med 1985;161:718-30.
14. Kennedy MJ, Vogelsang GB, Jones RJ, et al. Phase I trial of Interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1994;12:249-57.
15. Jones RJ, Vogelsang GB, Hess AD, et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989;1:754-7.
16. Kennedy MJ, Vogelsang GB, Beveridge RA, et al. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1993;11:478-84.
17. Aulitzky W, Gastl G, Aulitzky WE, et al. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncol 1989;7:1875-84.
18. Pati AR, Godder KT, Abhyankar SH, et al. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma. Bone Marrow Transplant 1996;17:1081-3.
19. Hess A, Bright E, Thoburn C, et al. Characterization of effector mechanisms in autologous graft-versus-host disease: role of MHC class II invariant chain peptide (CLIP). Blood 1995;86 (Suppl):624a.
20. Horowitz MM, Gale RP, Sondel PM. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555-62.